Skip to content
    Gilde Healthcare logo

    Gilde Healthcare

    Utrecht, NetherlandsFounded 1982
    gildehealthcare.comLinkedIn
    HealthcareClimate & Energy

    Gilde Healthcare is a specialized European healthcare investor headquartered in Utrecht, managing over €2.6 billion across two fund strategies: Venture & Growth and Private Equity. Its latest fund, Gilde Healthcare Venture & Growth VI, closed at €740 million in commitments, investing in healthtech, therapeutics, and climate solutions across Europe and North America.

    33% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (3 deals in the last 12 months vs 13 prior). Average disclosed round size is $66.3M (across 65 rounds with reported amounts).

    Find people at Gilde Healthcare on Goldilocks AI

    Portfolio

    67

    Fund Size

    $805M

    Top Stage

    Series B

    Last 12 Mo

    3

    Team

    ED

    Edwin de Graaf

    Managing Partner

    AF

    Arthur Franken

    General Partner Healthtech/TherapeuticsVenture&Growth

    BR

    Boyd Rutten

    Partner Private Equity

    EH

    Edward Hanlon

    Investment Director Venture&Growth

    BA

    Besmire Ahmati

    Senior Associate Investor Relations & Fundraising Support office

    CA

    Chris Allen

    Senior Associate HealthTech Venture&Growth

    AD

    Ariane de Marcillac

    Associate HealthTech Venture&Growth

    CS

    Camille Sinkora

    Analyst Private Equity

    DB

    Dirkjan Beugelsdijk

    CFO Support office

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    109 investments
    CompanyRoundAmountDate
    Adcendo ApS logoAdcendo ApSSeries C$75MApr 2026
    Endovascular Engineering logoEndovascular EngineeringSeries C$80MApr 2026
    Big Health logoBig HealthUnknown$23.7MFeb 2026
    ProVerum Medical logoProVerum MedicalSeries B—Aug 2025
    GT Medical Technologies logoGT Medical TechnologiesSeries D$53MJul 2025
    SpliceBio logoSpliceBioSeries B$135MJun 2025
    SSplice BioSeries B$135MJun 2025
    SSpyGlass Pharma, IncSeries D—Jun 2025
    Spyglass logoSpyglassSeries D$75MJun 2025
    Shoulder Innovations logoShoulder InnovationsSeries E$40MMar 2025
    GT Medical Technologies logoGT Medical TechnologiesSeries D$37MJan 2025
    FIRE1 logoFIRE1Unknown$120MJan 2025
    PPROVERUM LIMITEDSeries B$80MJan 2025
    SSideraSeries A$109MJan 2025
    GT Medical Technologies logoGT Medical TechnologiesSeries D$37MJan 2025
    Shoulder Innovations logoShoulder InnovationsSeries E$40MJan 2025
    Noema Pharma logoNoema PharmaSeries B—Dec 2024
    Adcendo ApS logoAdcendo ApSSeries B$135MNov 2024
    SSynox TherapeuticsPre-Seed$92MOct 2024
    Purespring logoPurespringSeries B$105MOct 2024
    PPurespring TherapeuticsSeries B$105MOct 2024
    Catalym logoCatalymSeries D$150MJul 2024
    Karius logoKariusSeries D—May 2024
    SSynox TherapeuticsSeries B$75MApr 2024
    Nalu logoNaluSeries E$65MMar 2024
    Page 1 of 5

    Top Co-Investors

    Forbion19 shared
    Ysios Capital14 shared
    New Enterprise Associates12 shared
    Sofinnova Partners12 shared
    Novo Capital12 shared
    Lightstone Ventures9 shared
    Polaris Partners8 shared
    OrbiMed8 shared
    Jeito Capital7 shared
    INKEF Capital7 shared
    Andera Partners7 shared
    HealthCap7 shared
    RA Capital Management7 shared
    Novartis Venture Fund6 shared
    The Invus Group, LLC6 shared
    Pura Vida Investments6 shared
    Longitude Capital6 shared
    Novo Holdings A/S6 shared
    MedTech Venture Partners5 shared
    Lightspeed Venture Partners5 shared

    Last updated: 7 October 2026